BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22074726)

  • 41. Improved glycemic control with use of continuous subcutaneous insulin infusion compared with multiple insulin injection therapy.
    Bell DS; Ovalle F
    Endocr Pract; 2000; 6(5):357-60. PubMed ID: 11141585
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bone status in adolescents with type 1 diabetes.
    Chobot AP; Haffke A; Polanska J; Halaba ZP; Deja G; Jarosz-Chobot P; Pluskiewicz W
    Diabetologia; 2010 Aug; 53(8):1754-60. PubMed ID: 20454951
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diabetes care in pediatric refugees from Africa or Middle East: experiences from Germany and Austria based on real-world data from the DPV registry.
    Prinz N; Konrad K; Brack C; Hahn E; Herbst A; Icks A; Grulich-Henn J; Jorch N; Kastendieck C; Mönkemöller K; Razum O; Steigleder-Schweiger C; Witsch M; Holl RW
    Eur J Endocrinol; 2019 Jul; 181(1):31-38. PubMed ID: 31075760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries.
    Danne T; Battelino T; Jarosz-Chobot P; Kordonouri O; Pánkowska E; Ludvigsson J; Schober E; Kaprio E; Saukkonen T; Nicolino M; Tubiana-Rufi N; Klinkert C; Haberland H; Vazeou A; Madacsy L; Zangen D; Cherubini V; Rabbone I; Toni S; de Beaufort C; Bakker-van Waarde W; van den Berg N; Volkov I; Barrio R; Hanas R; Zumsteg U; Kuhlmann B; Aebi C; Schumacher U; Gschwend S; Hindmarsh P; Torres M; Shehadeh N; Phillip M;
    Diabetologia; 2008 Sep; 51(9):1594-601. PubMed ID: 18592209
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current use of metformin in addition to insulin in pediatric patients with type 1 diabetes mellitus: an analysis based on a large diabetes registry in Germany and Austria.
    Konrad K; Datz N; Engelsberger I; Grulich-Henn J; Hoertenhuber T; Knauth B; Meissner T; Wiegand S; Woelfle J; Holl RW;
    Pediatr Diabetes; 2015 Nov; 16(7):529-37. PubMed ID: 25131985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin.
    Blak BT; Smith HT; Hards M; Curtis BH; Ivanyi T
    Diabet Med; 2012 Jul; 29(7):e13-20. PubMed ID: 22268988
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Variables associated with severe hypoglycemia in children and adolescents with type 1 diabetes: a population-based study.
    Blasetti A; Di Giulio C; Tocco AM; Verrotti A; Tumini S; Chiarelli F; Altobelli E
    Pediatr Diabetes; 2011 Feb; 12(1):4-10. PubMed ID: 20723102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential of education-based insulin therapy for achievement of good metabolic control: a real-life experience.
    Albrecht D; Puder J; Keller U; Zulewski H
    Diabet Med; 2011 May; 28(5):539-42. PubMed ID: 21480964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beneficial effects of flexible insulin therapy in children and adolescents with type 1 diabetes mellitus.
    Alemzadeh R; Palma-Sisto P; Parton E; Totka J; Kirby M
    Acta Diabetol; 2003 Sep; 40(3):137-42. PubMed ID: 14605970
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improved glycemic control after long-term insulin pump use in pediatric patients with type 1 diabetes.
    Scrimgeour L; Cobry E; McFann K; Burdick P; Weimer C; Slover R; Chase HP
    Diabetes Technol Ther; 2007 Oct; 9(5):421-8. PubMed ID: 17931050
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in treatment adherence and glycemic control during the transition to adolescence in type 1 diabetes.
    Rausch JR; Hood KK; Delamater A; Shroff Pendley J; Rohan JM; Reeves G; Dolan L; Drotar D
    Diabetes Care; 2012 Jun; 35(6):1219-24. PubMed ID: 22474040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Longitudinal Trajectories of Metabolic Control From Childhood to Young Adulthood in Type 1 Diabetes From a Large German/Austrian Registry: A Group-Based Modeling Approach.
    Schwandt A; Hermann JM; Rosenbauer J; Boettcher C; Dunstheimer D; Grulich-Henn J; Kuss O; Rami-Merhar B; Vogel C; Holl RW;
    Diabetes Care; 2017 Mar; 40(3):309-316. PubMed ID: 28007778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictors of increasing BMI during the course of diabetes in children and adolescents with type 1 diabetes: data from the German/Austrian DPV multicentre survey.
    Fröhlich-Reiterer EE; Rosenbauer J; Bechtold-Dalla Pozza S; Hofer SE; Schober E; Holl RW;
    Arch Dis Child; 2014 Aug; 99(8):738-43. PubMed ID: 24812301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.
    Doyle EA; Weinzimer SA; Steffen AT; Ahern JA; Vincent M; Tamborlane WV
    Diabetes Care; 2004 Jul; 27(7):1554-8. PubMed ID: 15220227
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is poor glycaemic control in diabetic patients a risk factor of myopia?
    Jacobsen N; Jensen H; Lund-Andersen H; Goldschmidt E
    Acta Ophthalmol; 2008 Aug; 86(5):510-4. PubMed ID: 18081906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial.
    Weintrob N; Benzaquen H; Galatzer A; Shalitin S; Lazar L; Fayman G; Lilos P; Dickerman Z; Phillip M
    Pediatrics; 2003 Sep; 112(3 Pt 1):559-64. PubMed ID: 12949284
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical effectiveness of biphasic insulin aspart 30:70 versus biphasic human insulin 30 in UK general clinical practice: a retrospective database study.
    Morgan CL; Evans M; Toft AD; Jenkins-Jones S; Poole CD; Currie CJ
    Clin Ther; 2011 Jan; 33(1):27-35. PubMed ID: 21397771
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Daily insulin doses and injection frequencies of neutral protamine hagedorn (NPH) insulin, insulin detemir and insulin glargine in type 1 and type 2 diabetes: a multicenter analysis of 51 964 patients from the German/Austrian DPV-wiss database.
    Laubner K; Molz K; Kerner W; Karges W; Lang W; Dapp A; Schütt M; Best F; Seufert J; Holl RW
    Diabetes Metab Res Rev; 2014 Jul; 30(5):395-404. PubMed ID: 24302583
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).
    Murata GH; Shah JH; Hoffman RM; Wendel CS; Adam KD; Solvas PA; Bokhari SU; Duckworth WC;
    Diabetes Care; 2003 Jun; 26(6):1759-63. PubMed ID: 12766106
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes: the U.K. DAFNE experience.
    Hopkins D; Lawrence I; Mansell P; Thompson G; Amiel S; Campbell M; Heller S
    Diabetes Care; 2012 Aug; 35(8):1638-42. PubMed ID: 22619082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.